SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 With the growing popularity of weight loss drugs like Ozempic, Wegovyn, ...

A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

Vivani Medical (VANI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 20. Analyst Naz ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

Hims & Hers faces regulatory hurdles but shows strong business growth. Find out why HIMS stock is a "Hold" despite setbacks ...

New research shows how weight loss meds like Wegovy are reshaping alcohol habits, offering new insights into addiction ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of ...